Attributes | Values |
---|
rdf:type
| |
Description
| - Série 6-alkyl-HPMP-5azaC byla připravena s využitím amoniakem katalyzovaného otevírání kruhu chráněného HPMP-5-azaC esteru, následnou kondenzací s orthoestery a deprotekcí esterových skupin. Zavedení mastných acylových skupin do polohy N4 bylo provedeno pomocí přislušných acyl chloridů reakcí s esterem HPMP-5-azaC nebo jeho cyklickou formou. (cs)
- A series of 6-alkyl-HPMP-5azaC was synthesized using ammonia mediated ring-opening reaction of protected HPMP-5-azaC ester followed by condensation reaction with orthoesters and deprotection of ester groups. Introduction of long chain acyl groups to the N4-position was performed using reaction of some acyl chloride (e.g. behenoyl chloride) and appropriate ester of HPMP-5-azaC or its cyclic form.
- A series of 6-alkyl-HPMP-5azaC was synthesized using ammonia mediated ring-opening reaction of protected HPMP-5-azaC ester followed by condensation reaction with orthoesters and deprotection of ester groups. Introduction of long chain acyl groups to the N4-position was performed using reaction of some acyl chloride (e.g. behenoyl chloride) and appropriate ester of HPMP-5-azaC or its cyclic form. (en)
|
Title
| - New antiviral agent, 1-(S)-[3-hydroxy-(2-phosphonomethoxy)propyl]-5-azacytosin: esters and base modified derivatives
- Nové virostatikum, 1-(S)-[3-hydroxy-(2-phosphonomethoxy)propyl]-5-azacytosin: estery a modifikované baze (cs)
- New antiviral agent, 1-(S)-[3-hydroxy-(2-phosphonomethoxy)propyl]-5-azacytosin: esters and base modified derivatives (en)
|
skos:prefLabel
| - New antiviral agent, 1-(S)-[3-hydroxy-(2-phosphonomethoxy)propyl]-5-azacytosin: esters and base modified derivatives
- Nové virostatikum, 1-(S)-[3-hydroxy-(2-phosphonomethoxy)propyl]-5-azacytosin: estery a modifikované baze (cs)
- New antiviral agent, 1-(S)-[3-hydroxy-(2-phosphonomethoxy)propyl]-5-azacytosin: esters and base modified derivatives (en)
|
skos:notation
| - RIV/61388963:_____/08:00309993!RIV09-AV0-61388963
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(1M0508), P(1QS400550501), Z(AV0Z40550506)
|
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61388963:_____/08:00309993
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - HPMP-5-azaC; antiviral; ring-opening (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...v/mistoKonaniAkce
| |
http://linked.open...i/riv/mistoVydani
| |
http://linked.open...i/riv/nazevZdroje
| - Chemistry of Nucleic Acid Components
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...iv/tvurceVysledku
| - Andrei, G.
- Balzarini, J.
- Holý, Antonín
- Krečmerová, Marcela
- Snoeck, R.
- De Clercq, E.
- Pískala, Alois
|
http://linked.open...vavai/riv/typAkce
| |
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open.../riv/zahajeniAkce
| |
http://linked.open...n/vavai/riv/zamer
| |
number of pages
| |
http://purl.org/ne...btex#hasPublisher
| - Institute of Organic Chemistry and Biochemistry ASCR
|
https://schema.org/isbn
| |